Granules India receives USFDA nod for Methylergonovine tablets
Granules India has received USFDA’s approval for Methylergonovine 0.2 mg tablets. The abbreviated new drug applications (ANDA) was filed by Granules Pharmaceuticals Inc., a wholly...
Tag : Granules India
Granules India gets EIR from USFDA for Jeedimetla facility
Granules India has received Establishment Inspection Report (EIR), from the US health regulator for facility in Telangana. The US Food and Drug Administration inspected Jeedimetla facility...
Granules India receives establishment inspection report from USFDA
Granules India has received EIR from US Food and Drug Administration (USFDA), for Chantilly unit. USFDA has issued establishment inspection report (EIR) for Granules Pharmaceuticals,...
Granules India receives EIR for Vizag OmniChem faclitiy from USFDA
Granules India, has received Establishment Inspection Report(EIR), for the OmniChem facility at Vizag, Andhra Pradesh, from the US health regulator. In a BSE filing it...
Granules India receives board approval to raise foreign limit to 49%
Granules India‘s board has provided its approval to the proposal to increase the foreign investment limit in the company to 49 percent. Granules India has...
Granules’ board has approved Rs 167 crore investment proposal
The board of Granules India has given its approval for investment of about Rs 167 crore in various arms. Granules India has said in a...